These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27998881)

  • 1. Cholesterol paradox: a correlate does not a surrogate make.
    DuBroff R
    Evid Based Med; 2017 Mar; 22(1):15-19. PubMed ID: 27998881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
    Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW
    Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does lowering serum cholesterol levels lower coronary heart disease risk?
    Rossouw JE; Rifkind BM
    Endocrinol Metab Clin North Am; 1990 Jun; 19(2):279-97. PubMed ID: 2192874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholesterol-lowering treatment on coronary heart disease morbidity and mortality: the evidence from trials, and beyond.
    Katan MB
    Cardiology; 1990; 77 Suppl 4():8-13. PubMed ID: 2073675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypercholesterolemia and coronary disease: intervention strategies].
    Brunelli C; Spallarossa P; Saccani A; Corsiglia L; Ghigliotti G; Caponnetto S
    Cardiologia; 1991 Dec; 36(12 Suppl 1):303-8. PubMed ID: 1841785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol and cardiovascular disease: how strong is the evidence?
    LaRosa JC
    Clin Cardiol; 1992 Nov; 15(11 Suppl 3):III2-7; discussion III8-9. PubMed ID: 1477994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol and cardiovascular disease: how strong is the evidence?
    LaRosa JC
    Clin Cardiol; 1992 Nov; 15(11):III2-7; discussion III8-9. PubMed ID: 1458693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of cholesterol in coronary heart disease risk reduction.
    Woodhead GA
    Nurse Pract; 1996 Sep; 21(9):45, 48, 51-3. PubMed ID: 8884794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein cholesterol: is lower better?
    Leiter LA
    Can J Cardiol; 2000 Jan; 16 Suppl A():20A-2A. PubMed ID: 10653927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    Lincoff AM; Nicholls SJ; Riesmeyer JS; Barter PJ; Brewer HB; Fox KAA; Gibson CM; Granger C; Menon V; Montalescot G; Rader D; Tall AR; McErlean E; Wolski K; Ruotolo G; Vangerow B; Weerakkody G; Goodman SG; Conde D; McGuire DK; Nicolau JC; Leiva-Pons JL; Pesant Y; Li W; Kandath D; Kouz S; Tahirkheli N; Mason D; Nissen SE;
    N Engl J Med; 2017 May; 376(20):1933-1942. PubMed ID: 28514624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A hypothesis prevails: cholesterol and coronary heart disease].
    Battegay E
    Praxis (Bern 1994); 1998 Oct; 87(43):1425-7. PubMed ID: 9844486
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The facts about cholesterol (condensed translation and comments of the common declaration of AHA and NHLBI)].
    Jacotot B; Delahaye F
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():83-6. PubMed ID: 1296550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterolemia and pathology: update].
    Schlienger JL; Goichot B; Pradignac A
    Rev Med Interne; 1998 Mar; 19(3):180-4. PubMed ID: 9775138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholesterol: consensus and controversies, what is the trend in 1993?].
    Fossati P
    Ann Endocrinol (Paris); 1993; 54(6):389-97. PubMed ID: 7944281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol reduction to prevent CAD. What do the data show?
    Sorrentino MJ
    Postgrad Med; 2000 Dec; 108(7):40-2, 45-6, 49-52. PubMed ID: 11126142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering serum cholesterol: who benefits?
    Allred JB
    J Nutr; 1993 Aug; 123(8):1453-9. PubMed ID: 8336217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.